Elizabeth Hurlburt

COO · CorMedix Inc.

Rank #19,133 SEC EDGAR (United States) ↗

Details

Officer of the companyPharmaceuticals & BiotechnologyCRMDSEC CIK 0001735256

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$2.3M
1-day change
▼ 0.47%
Positions on file
1
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 1 currently disclosed position would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$1.7M – $3.6M2026-09-04

Insider activity Nov 14, 2024 – Feb 4, 2026

Elizabeth Hurlburt is recorded in filings to the U.S. SEC via EDGAR as officer of the company, and reported 21 transactions between Nov 14, 2024 and Feb 4, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
None
0 purchases on file
Open-market sales (code S)
$2.28M
3 sales on file priced rows only
All reported transactions
21
every code, including awards and exercises
Pattern
Net seller in the final 12 months of the window
last 12 months of the window

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 22 most recent rows are grouped into 17 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. CorMedix Inc. CRMD F Shares withheld for taxesnot a buy/sell decision 8,076 shares $67.0K at $8.30 SEC filing ↗
  2. CorMedix Inc. CRMD A Grant or awardnot a buy/sell decisionreported at zero 36,006 shares $0 at $0.00 SEC filing ↗
  3. CorMedix Inc. CRMD A Grant or awardnot a buy/sell decisionreported at zero 93,010 shares $0 at $0.00 SEC filing ↗
  4. CorMedix Inc. CRMD F Shares withheld for taxesnot a buy/sell decision 10,778 shares $78.4K at $7.27 SEC filing ↗
  5. CorMedix Inc. CRMD F Shares withheld for taxesnot a buy/sell decision 5,794 shares $41.4K at $7.15 SEC filing ↗
  6. CorMedix Inc. CRMD F Shares withheld for taxesnot a buy/sell decision 10,895 shares $132.5K at $12.16 SEC filing ↗
  7. CorMedix Inc. CRMD S Open-market sale 41,121 shares $537.9K at $13.08 SEC filing ↗
  8. CorMedix Inc. CRMD M Option exercise or conversionnot a buy/sell decision 41,121 shares $59.6K at $1.45 SEC filing ↗
  9. CorMedix Inc. CRMD M Option exercise or conversionnot a buy/sell decision 12,876 shares $18.7K at $1.45 SEC filing ↗
  10. CorMedix Inc. CRMD S Open-market sale 12,876 shares $174.0K at $13.51 SEC filing ↗
  11. CorMedix Inc. CRMD A Grant or awardnot a buy/sell decisionreported at zero 69,686 shares $0 at $0.00 SEC filing ↗
  12. CorMedix Inc. CRMD F Shares withheld for taxesnot a buy/sell decision 8,424 shares $124.9K at $14.83 SEC filing ↗
  13. CorMedix Inc. CRMD F Shares withheld for taxesnot a buy/sell decision 5,790 shares $64.8K at $11.19 SEC filing ↗
  14. CorMedix Inc. CRMD A Grant or awardnot a buy/sell decisionreported at zero 87,500 shares $0 at $0.00 SEC filing ↗
  15. CorMedix Inc. CRMD F Shares withheld for taxesnot a buy/sell decision 11,378 shares $93.5K at $8.22 SEC filing ↗
  16. CorMedix Inc. CRMD M Option exercise or conversion × 6not a buy/sell decision 140,027 shares $627.7K
    The 6 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    3 $1.45 $4 SEC filing ↗
    8,169 $8.30 $67.8K SEC filing ↗
    9,888 $5.63 $55.7K SEC filing ↗
    34,467 $4.08 $140.6K SEC filing ↗
    62,500 $4.43 $276.9K SEC filing ↗
    25,000 $3.47 $86.8K SEC filing ↗
  17. CorMedix Inc. CRMD S Open-market sale 140,027 shares $1.57M at $11.18 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
CorMedix Inc. CRMD Common Stock 278,539 $8.43 $2.3M 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Elizabeth Hurlburt reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.